Guild Investment Management’s BioMarin Pharmaceuticals BMRN Stock Holding History

Guild Investment Management’s Portfolio BMRN Stock Details BMRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-11,940	Closed	-$1.02M	–	58
2022 Q2	$1.02M	Sell	11,940 -630	-5%	-$50.2K	1.54%	27
2022 Q1	$969K	Sell	12,570 -19	-0.2%	-$1.59K	0.99%	35
2021 Q4	$1.11M	Buy	12,589 +9	+0.1%	+$743	1.13%	29
2021 Q3	$972K	Sell	12,580 -116	-0.9%	-$9.15K	0.94%	35
2021 Q2	$1.06M	Buy	12,696 +3,196	+34%	+$253K	1.03%	37
2021 Q1	$717K	Buy	9,500 +590	+7%	+$48.2K	0.77%	40
2020 Q4	$781K	Buy	8,910 +5,990	+205%	+$475K	0.86%	40
2020 Q3	$222K	Sell	2,920 -10	-0.3%	-$1.01K	0.31%	43
2020 Q2	$361K	Buy	+2,930	New	+$291K	0.51%	39

Other funds holding BMRN

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Guild Investment Management's BMRN Position: Q3 2022 in Review

Guild Investment Management sold out of BioMarin Pharmaceuticals (BMRN) in Q3 2022, closing a stake of 11,940 shares — an estimated $1.02M sold.

Guild Investment Management first reported a position in BMRN in Q2 2020 and held it in 9 quarters. The position peaked at $1.11M in Q4 2021. 551 funds tracked by Wall St. Rank hold BMRN as of Q3 2022.

Guild Investment Management reported no remaining BioMarin Pharmaceuticals position as of Q3 2022 after selling out during the quarter.
Guild Investment Management sold 11,940 BioMarin Pharmaceuticals shares in Q3 2022, an estimated $1.02M.
Guild Investment Management first reported a position in BioMarin Pharmaceuticals in Q2 2020 and held it in 9 quarters.
Guild Investment Management's BioMarin Pharmaceuticals position peaked at $1.11M in Q4 2021.
551 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q3 2022.

Based on Guild Investment Management's 13F filing for Q3 2022, filed 12 Oct 2022.